Global Health Collaboration: Development of a new schistosomiasis diagnostic tool
12 OCT 2020
We join forces to accelerate development and access to a rapid diagnostic test (RDT) for schistosomiasis.
Schistosomiasis is a neglected tropical disease affecting over 220 million people.
To control the disease, rapid diagnostic tests (RDTs) are urgently needed in order to simplify the testing and guide targeted deployment of treatment campaigns in community settings.
Together with global health partners, we have developed a prototype. A new collaboration will now build on this, to accelerate the development and validation of an innovative RDT for schistosomiasis.
“We are committed to fight schistosomiasis until its elimination. To achieve this goal, it requires delivering integrated health solutions, including drugs and diagnostics to the communities in need” said Béatrice Gréco, Head of R&D and Access at the Global Health Institute. “This international collaboration is an essential element of such a strategy as it addresses the major gap of providing an accessible diagnostic tool to health systems in endemic countries”.